Bachem has announced that at the annual general meeting of Bachem Holding on 22 April 2009 Dr Jürgen Brokatzky-Geiger was elected as a new member of the board of directors by a vast majority. He will replace
Dr François L’Eplattenier, who retires due to the age limit.
Dr Jürgen Brokatzky-Geiger (born 1952) graduated with a Ph.D. in chemistry from the
University of Freiburg, Germany, in 1982. He joined Ciba-Geigy in 1983 as a laboratory
head in the pharmaceuticals division. After a job rotation in the United States, he held
positions of increasing responsibility in research and development (R&D) including group
leader of process R&D, head of process R&D, and head of process development and pilot
plant operations.
During the merger of Ciba-Geigy and Sandoz in 1996, Dr Jürgen Brokatzky-Geiger was
appointed integration officer of technical operations. He later became the head of chemical
and analytical development and served as the global head of technical R&D from 1999 to
August 2003. Dr Jürgen Brokatzky-Geiger was appointed to his present position as head of
human resources on 1 September 2003. He has been a member of the executive committee
of Novartis since 1 January 2005.
Peter Grogg, chairman of the board of directors, commented, “With Dr Jürgen Brokatzky-
Geiger we could win a highly qualified and internationally experienced specialist in the area of
life sciences for our board of directors. Owing to his activity he has strong knowledge of our
core business. We wish him success in the board of directors of Bachem Holding AG.”